Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hatanaka, Y.
Right arrow Articles by Miyao, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hatanaka, Y.
Right arrow Articles by Miyao, M.

Radiology, Vol 195, 747-752, Copyright © 1995 by Radiological Society of North America

ARTICLES

Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management

Y Hatanaka, Y Yamashita, M Takahashi, Y Koga, R Saito, K Nakashima, J Urata and M Miyao
Department of Radiology, Kumamoto University School of Medicine, Japan.

PURPOSE: To evaluate the effect of transcatheter management of hepatocellular carcinoma (HCC) on survival. MATERIALS AND METHODS: A prospective trial of transcatheter arterial embolization (TAE) was performed in patients with unresectable HCC. Three hundred twenty-two patients (265 men, 57 women; age range, 30-83 years) underwent TAE alone: 60 patients underwent TAE with gelatin sponge (GS) that contained anticancer agents (protocol 1); 78, TAE with GS and iodized oil mixed with anticancer agents (protocol 2); and 159, TAE with iodized oil with anticancer agents (protocol 3). A Cox proportional hazard model was used to analyze prognostic factors. RESULTS: In the randomized group (n = 272), survival rates for protocols 1, 2, and 3 were 80.4%, 86.3%, and 65.9%, respectively, at 1 year. Findings of analysis of prognostic factors showed that extrahepatic metastases, ascites, tumor extension, and icterus were the important factors. CONCLUSION: TAE with GS was superior to TAE without GS. Patient characteristics were important factors for survival.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
D. B. Brown, W. C. Chapman, R. D. Cook, J. R. Kerr, J. E. Gould, T. K. Pilgram, and M. D. Darcy
Chemoembolization of Hepatocellular Carcinoma: Patient Status at Presentation and Outcome over 15 Years at a Single Center
Am. J. Roentgenol., March 1, 2008; 190(3): 608 - 615.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. D. Seo, H. C. Lee, M. K. Jang, H. J. Min, K. M. Kim, Y. S. Lim, Y.-H. Chung, Y. S. Lee, D. J. Suh, G.-Y. Ko, et al.
Preoperative Portal Vein Embolization and Surgical Resection in Patients with Hepatocellular Carcinoma and Small Future Liver Remnant Volume: Comparison with Transarterial Chemoembolization
Ann. Surg. Oncol., December 1, 2007; 14(12): 3501 - 3509.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
R. W. Sze, R. A. Hopper, V. Ghioni, J. S. Gruss, R. G. Ellenbogen, D. King, A. V. Hing, and M. L. Cunningham
MDCT Diagnosis of the Child with Posterior Plagiocephaly
Am. J. Roentgenol., November 1, 2005; 185(5): 1342 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Ikeda, S. Okada, S. Yamamoto, T. Sato, H. Ueno, T. Okusaka, H. Kuriyama, K. Takayasu, H. Furukawa, and R. Iwata
Prognostic Factors in Patients with Hepatocellular Carcinoma Treated by Transcatheter Arterial Embolization
Jpn. J. Clin. Oncol., November 1, 2002; 32(11): 455 - 460.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
C. Camma, F. Schepis, A. Orlando, M. Albanese, L. Shahied, F. Trevisani, P. Andreone, A. Craxi, and M. Cottone
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
Radiology, July 1, 2002; 224(1): 47 - 54.
[Abstract] [Full Text]

Home page
 Am. J. Roentgenol.Home page
K. Numata, K. Tanaka, T. Kiba, S. Matsumoto, S. Iwase, K. Hara, H. Kirikoshi, K. Morita, S. Saito, and H. Sekihara
Nonresectable Hepatocellular Carcinoma: Improved Percutaneous Ethanol Injection Therapy Guided by CO2-Enhanced Sonography
Am. J. Roentgenol., October 1, 2001; 177(4): 789 - 798.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. Caturelli, D. A. Siena, S. Fusilli, M. R. Villani, G. Schiavone, M. Nardella, S. Balzano, and F. Florio
Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma in Patients with Cirrhosis: Evaluation of Damage to Nontumorous Liver Tissue-Long-term Prospective Study
Radiology, April 1, 2000; 215(1): 123 - 128.
[Abstract] [Full Text]

Home page
 RadiologyHome page
T. de Baere, P. Taourel, J. M. Tubiana, V. Kuoch, M. Ducreux, J. Lumbroso, and A. J. Roche
Hepatic Intraarterial 131I Iodized Oil for Treatment of Hepatocellular Carcinoma in Patients with Impeded Portal Venous Flow
Radiology, September 1, 1999; 212(3): 665 - 668.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1995 by the Radiological Society of North America.